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ABSTRACT 
 
Apoptosis triggered by exogenous and endogenous stimuli such as ultraviolet radiation, oxi-
dative stress, and genotoxic chemicals is a crucial phenomenon within biological systems. 
DNA damage activates and stabilizes p53 in nucleus and cytoplasm and regulates other pro-
teins that stimulate intrinsic and extrinsic apoptotic pathways. Apoptosis is morphologically 
distinct from that of necrosis and both the phenomena depend on the types, developmental 
stages, physiological environment of tissues and the nature of death signal. Malfunctioning of 
apoptotic pathway may cause human diseases like cancer, neurodegenerative and autoimmune 
disorders. Recently, potent apoptosis-inducing compounds associated with human health have 
been recorded that prevent tumor promotion, progression, and the occurrence of cellular in-
flammatory responses. Certain photosensitizing drugs are being employed in photodynamic 
therapy to induce apoptosis for the treatment of cancer and non-cancerous cells. This review 
emphasizes the molecular mechanisms of apoptosis, associated diseases and certain therapeu-
tic agents implicated in the elimination of malignant cells.    
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INTRODUCTION 
 
In addition to cell-cycle arrest and re-
pair machinery, the damaged cells, where 
damage is beyond repair, may induce an 
apoptotic (programmed cell death; PCD) 
response that is highly cell-specific and is 
the most common form of physiologic cell 
death in multicellular forms. The concept of 
PCD was first developed by plant biologists 
in 1920s (Jones, 2001). In unicellular or-
ganisms the mechanisms of PCD is less un-
derstood in comparison to metazoan, how-
ever some workers assume it as unicellular 
origin with a later adoption by multicellular 
life (Ameisen, 2002). Apoptosis play an 
essential role in survival of the organisms 
and is considered to be an imperative com-
ponent of various processes including nor-
mal cell turnover, proper development and 
functioning of the immune system, multi-
plication of mutated chromosomes, hor-
mone-dependent atrophy, normal embry-
onic development, elimination of indis-
posed cells and maintenance of cell homeo-
stasis (Reed & Tomaselli, 2000; Elmore, 
2007). DNA damage and production of the 
predominant lesions such as cyclobutane 
pyrimidine dimers (CPDs), 6–4 photopro-
ducts (6–4PPs) and certain other lesions 
(Sinha & Häder, 2002; Kumari et al., 2008) 
as a result of UV radiation (UVR), ionizing 
radiation (IR), oxidative stress, replication 
or recombination errors as well as from en-
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vironmental and therapeutic genotoxins is 
one of the principal triggers of apoptosis 
(Nagata, 1997; Norbury & Zhivotovsky, 
2004; Batista et al., 2009). 
UVR (mostly UV-B; 280–315 nm) is 
one of the most potent carcinogens that af-
fect the normal life processes of all organ-
isms ranging from bacteria to human 
(Häder & Sinha, 2005; Friedberg et al., 
2006). UV radiation is a DNA damaging 
agent that activates and stabilizes p53 in 
nucleus as well as in cytoplasm and regu-
lates a number of genes which stimulate 
two major apoptotic pathways: the intrinsic 
and the extrinsic pathways (Haupt et al., 
2003). A key tumor suppressor p53, suscep-
tible to DNA damage induced apoptosis 
(DDIA) (Clarke et al., 1993) is functionally 
conserved in multicellular animals such as 
Caenorhabditis elegans (Cep-1) to human 
cells (Schumacher et al., 2001), but is ap-
parently absent from unicellular species 
(Norbury & Zhivotovsky, 2004). The apop-
totic regulators in C. elegans such as Egl-1, 
Ced-9, Ced-4, and Ced-3 show homology 
with mammalian apoptotic proteins such as 
BH3, Bcl-2, Apaf-1, and Casp-9 respec-
tively, which indicates a highly conserved 
cell death mechanism that exists in worms 
and mammals (Jiang & Wang, 2004) (Fig-
ure 1). Activation of p53 by DNA damage 
can lead to apoptosis by transcriptional ac-
tivation of pro-apoptotic members of Bcl-2 
family, such as Puma, Noxa, Bim, Bid, Bik, 
Bak, Bax, Apaf-1, Bmf, Hrk, Pag608, Drs, 
Fas and Gadd45 (Vogelstein et al., 2000; 
Vousden and Lu, 2002; Tian et al., 2007). 
This diverse family includes multidomain 
pro-apoptotic (e. g. Bax, Bak), anti-a pro-
grammed cell death (PCD apoptotic (e. g. 
Bcl-2, Bcl-XL, Mcl-1) as well as a number 
of BH3 only (e. g. Puma, Noxa, Bid, etc.) 
proteins that together regulate mitochon-
drial permeability (Cory & Adams, 2002). 
However, the relevance of transcriptional 
activation in p53 apoptosis in human cancer 
is highly controversial. Kakudo et al. 
(2005) have shown that p53 mediated 
transactivation does not play a major role in 
p53 dependent apoptosis. The study of 
mouse fibroblasts treated with different 
doses of UV and γ irradiations has also re-
vealed the primary response mediated by 
p53 transcriptional activation as anti-
apoptotic, whereas pro-apoptotic response 
requires an additional, transcriptional-
independent mechanism (Speidel et al., 
2006). Generally senescent cells are resis-
tant to apoptosis induced by genotoxic 
stress and the study of  pre-senescent pri-
mary human diploid foreskin fibroblasts has 
also revealed that pass aging cells results in 
progressive acquisition of resistance to UV-
induced apoptosis in the presence of BCL-
2- family proteins (Rochette & Brash, 
2008). 
 
 
 
Figure 1: Programmed cell death in C. elegans and mammals showing highly conserved cell death 
machinery (in box), A (CEP-1/p53), B (Egl-1/BH3), C (Ced-9/Bcl-2), D (Ced-4/Apaf-1) and E (Ced-
3/Casp-9). 
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Recently, Wu et al. (2008) have con-
firmed that both p53 transcription-
dependent and independent pathways con-
tribute to UV-induced apoptosis. In cells, 
the level of p53 is maintained through its 
MDM2-mediated degradation. Several lines 
of evidence show that transcriptional-
independent p53 apoptosis (Erster et al., 
2004; Yu, 2006) is directly linked to the 
intrinsic or mitochondrial apoptotic path-
way (Chipuk et al., 2004; Leu et al., 2004), 
where it interacts with anti-apoptotic Bcl-2 
family proteins (Bcl-2, Bcl-XL) and stop 
their action to promote the activities of 
BH3-only proteins (Bak/Bax). Pro-apop-
totic Bax/Bak are essential regulators of the 
mitochondrial or intrinsic pathway of apop-
tosis (Ranger et al., 2001). Bak resides 
permanently on the outer mitochondrial 
membrane (OMM), whereas Bax is nor-
mally found in the cytosol of healthy or 
UV-unirradiated cells, which translocates to 
the outer mitochondrial membrane during 
apoptosis (Gross et al., 1998). Wu et al. 
(2007) have demonstrated that translocation 
of Bax by the incidence of UV irradiation is 
a Bid-independent event, inhibited by over-
expression of Bcl-xL and delayed by the 
p53 inhibitor. P53 plays an important role 
in Bax conformational change induced by 
UV radiation. The molecular mechanisms 
of Bax activation is not clearly understood, 
however, Chen et al. (2007) have shown the 
role of BimL in Bax activation during UV 
irradiation-induced apoptosis. Confocal mi-
croscopic studies has revealed the cyto-
plasmic distribution of BimL before UV 
irradiation, but after UV irradiation BimL 
translocated to mitochondria, although how 
Bim activates Bax to induce apoptosis, di-
rectly or indirectly is not clear (Marani et 
al., 2002; Zhu et al., 2004). The transcrip-
tional factor E2Fs (E2F1-3) may also in-
duce apoptosis either dependent or inde-
pendent of p53. In later case E2Fs directly 
activates p53 related protein p73 (Irwin et 
al., 2000). p73-induced apoptosis is medi-
ated by induction of a BH3-only protein 
PUMA, which leads to Bax mitochondrial 
translocation and release of cytochrome-c 
and triggers cell death (Ramadan et al., 
2005). Recently, it has been found that 
TFDP3 is a negative regulator of E2F-1 in-
duced apoptosis (Tian et al., 2007; Qiao et 
al., 2007). Some cells express Fas or TNF 
receptors that can lead to apoptosis via 
ligand binding and protein cross-linking. 
Other cells have a default death pathway 
that must be blocked by a survival factor 
such as a hormone or growth factor. Even 
though, a number of key apoptotic proteins 
have been recognized; the molecular 
mechanisms of action of these proteins re-
main to be elucidated. It seems that apop-
tosis is a synchronized and frequently en-
ergy-dependent course of action that in-
volves the activation of a set of cysteine 
proteases known as “caspases” and a com-
plex cascade of events that link the initiat-
ing stimuli to the ultimate demise of the 
cell. Apoptosis has been recognized as a 
typical and important mode of “pro-
grammed” cell death, which involves the 
genetically determined elimination of cells 
(Guicciardi & Gores, 2009). However, sev-
eral other forms of PCD have been illus-
trated and quite a number of other forms of 
PCD may yet be discovered (Formigli et al., 
2000; Sperandio et al., 2000; Debnath et al., 
2005; Qiao et al., 2007). The main objec-
tive of this review is to provide an overview 
of existing knowledge on the molecular 
mechanisms of apoptosis. 
 
Caspase (cysteine protease) 
Organization 
Caspases (c: cysteine protease mecha-
nism, aspase: ability to cleave after aspartic 
acid) are aspartate-directed cysteine prote-
ases that play a key role in the initiation and 
execution of apoptosis or PCD, necrosis 
and inflammation, failure of which may 
cause tumor development and several auto-
immune diseases (Danial & Korsmeyer, 
2004; Ghavami et al., 2009; Green et al., 
2009). Structural details of several caspases 
(such as Casp-1, 2, 3, 7, 8 and 9) (Yan & 
Shi, 2005) have been described and it was 
found that in most cases, the functional 
caspase unit is a homodimer, with each 
monomer having a large (~17-21 kDa) and 
a small (~10-13 kDa) subunit (Nicholson, 
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1999; Tait & Green, 2008) (Figure 2). 
Components of the proteolytic mechanism, 
including the active site Cys and His resi-
dues, are harboured within the large subunit 
while aspartate (Asp) at the P1 site (P1Asp) 
is obscured in a cavernous pocket, ex-
pressed as S1 site, are derived from both the 
large as well as small subunits and the S2, 
S3, and S4 subsites are contributed by the 
small subunit and thus both the small as 
well as large subunits determine the active 
site (Earnshaw et al., 1999). Recently, it has 
been found that the active site is made up of 
five protruding loops (L1-L4 and L2') 
which are conserved in all caspases. Loop 
L1-L4 are present on one monomer and L2' 
on the nearby monomer. All the four loops 
together decide the sequence specificity of 
the substrates and the active site 
conformation is stabilized by the L2' loop 
from the adjacent monomer (Yan & Shi, 
2005). Caspases are synthesized as zymo-
gens where N-terminal prodomain is fol-
lowed by the sequence programming of a 
large and subsequently a small subunit. The 
crystal structure of active caspase has re-
vealed its tetramer structure (resulting from 
combination of two procaspase zymogens) 
containing two large subunits (homodimer) 
and two small subunits (heterodimer) 
folded into a dense canister having a central 
six-stranded β-sheet flanked by five helices. 
In the tetramer which is formed by the pro-
domain-facilitated dimerization of caspase, 
two of these cylinders align in a head-to-tail 
configuration, so that the two active sites 
are at opposite ends of the molecule (Fig-
ure 3) (Nicholson, 1999; Boatright & 
Salvesen, 2003; Yan & Shi, 2005). The ini-
tiator caspases contain death domain (DD) 
such as a caspase activation and recruitment 
domain (CARD) (e. g. caspases-1, 2, 4 and 
9) or a death effector domain (DED) (e. g. 
caspases-8 and 10) (Figure 2) which facili-
tates caspases to act together with other 
molecules that direct their activation. The 
DED has been found to be involved in in-
teractions with DEDs of signaling adapter 
proteins such as MORT1/FADD and 
TRADD (Hsu et al., 1995; Boldin et al., 
1996). The CARD protein interaction motif 
is conserved among multiple key apoptotic 
regulators such as caspases, adaptor mole-
cules RAIDD and Apaf-1, and inhibitors of 
apoptosis c-IAP1 and c-IAP2 (Ho & Haw-
kins, 2005). 
 
 
 
Figure 2: Graphic illustration showing the organization of mammalian initiator proteases (procas-
pases) having either CARD (e. g. caspase-2 and 3) or two DEDs (e. g. caspase-8) associated with 
long prodomain. The proteolytic cleavage (shown by arrow) takes place at specific sites during the 
production of the active enzyme. The active site of a caspase is determined by the four loops (L1-4). 
Monomeric form of caspases are generally formed by two subunits, i. e., a large (~17-21 kDa) and a 
small (~10-13k Da) subunit. 
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Figure 3: Diagrammatic view of initiator procaspase-8 activation. The zymogens of initiator procas-
pase exist as suppressed monomers. The prodomain of caspase-8 consists of two DED. The large 
and small subunits are shown by ‘L’ and ‘S’ respectively. The dimerization of monomeric units of cas-
pase results into active dimeric caspase due to their proteolytic activation. The active dimeric caspase 
has two active-sites whose conformation is conserved in all known caspases. 
 
 
Activation 
Generally, caspases occur in the cells in 
an inactive form (i. e., procaspase) and once 
activated can trigger other caspases leading 
to amplification of apoptotic signaling 
pathway followed by cell death due to their 
proteolytic activity. Caspases are widely 
expressed in an inactive proenzyme (zymo-
gens) form in most cells and are stimulated 
by an autoproteolytic mechanism or by 
meting out by other proteases and once ac-
tivated can often activate other procaspases, 
allowing initiation of a protease cascade. 
Some pro-caspases can also aggregate and 
autoactivate. This proteolytic cascade, in 
which one caspase can activate other cas-
pases, amplifies the apoptotic signaling 
pathway and thus leads to rapid cell death. 
At least 14 mammalian caspases (caspase- 1 
to 14) have been recognized that can be 
categorized into three functional groups 
such as initiators (e. g., casp-2, 8, 9 and 10), 
effectors (e. g., casp-3, 6 and 7) and the 
prototypical member of a subclass of cas-
pases involved in cytokine activation 
termed inflammatory caspases (casp-1, 4, 5, 
11, 12 and 13) (Table 1) (Cohen, 1997; Rai 
et al., 2005; Elmore, 2007; Martinon & 
Tschopp, 2007; Pop & Salvesen, 2009). 
The term ‘inflammatory’ has been given as 
the main caspase-1 substrates recognized to 
date are proIL-1β (interleukin-1β) and 
proIL-18, two related cytokines that play 
critical roles in inflammation (Fischer et al., 
2002). The specific substrates of mouse 
caspase-11 and caspase-12 and human cas-
pase-4 and caspase-5 are not yet known, 
hence the specific functions of these cas-
pases are still an open issue. However, Mar-
tinon & Tschopp (2007) have tried to dis-
cuss the current role of these caspases. The 
molecular mechanisms concerned with the 
activation of these inflammatory proteases 
have revealed the significant role for the 
NLR (NOD-like receptors) family mem-
bers, NALPs (NALP1, 2 and 3), NAIP 
(neuronal apoptosis inhibitory protein) and 
IPAF (ICE protease-activating factor) pro-
teins that promote the assembly of multi-
protein complexes termed inflammasomes 
(Figure 4A), which are essential for activa-
tion of inflammatory caspases (Martinon & 
Tschopp, 2007). It has been found that cas-
pase-11 regulates apoptosis and cytokine 
maturation during septic shock, caspase-12 
intervenes endoplasmic-specific apoptosis 
and cytotoxicity by amyloid-β. The gene for 
caspase 12 is found on chromosome 11 in 
humans in a locus with other inflammatory 
caspases (Fischer et al., 2002). Caspase-13 
(also known as Evolutionarily Related In-
terleukin-1β Converting Enzyme": ERICE) 
was identified in cattle and was originally 
reported as a human caspase that could be 
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activated by caspase 8 (Humke et al., 1998) 
but later on caspase-13 was established as a 
bovine gene (Koenig et al., 2001). The 
exact function of caspase-14 is still not 
known, however, its occurrence has been 
found very specifically in the skin and 
supposed not to be involved in apoptosis or 
inflammation, but plays an important role in 
skin cell development, maintaining the 
balance of moisture in the skin, and 
protection against UV-B rays (Denecker et 
al., 2007, 2008). It has been concluded that 
the caspase-14-activating protease is not a 
caspase but most likely an epidermis-
specific serine protease with elastase-like 
properties (Denecker et al., 2007). Recent-
ly, it has been observed that inflammatory 
caspases are essential in promoting a pro-
inflammatory microenvironment and 
influencing increased epithelial cell death in 
the target tissues of Sjögren's syndrome 
(SjS) before disease onset (Bulosan et al., 
2009). 
The activation of an effector caspase, 
such as caspase-3, 6 or 7 is performed by an 
initiator caspase, such as caspase-2, 8, 9, or 
10, through internal cleavages to separate 
the large and small subunits (Yan & Shi, 
2005). The activation of these initiator cas-
pases depends significantly on the com-
mitment and establishment of recruitment 
platforms e. g., the death inducing signaling 
complex (DISC) (Figure 4B) for caspase-8 
and caspase-10, the PIDDosome (Fig-
ure 4C) (having adaptor RAIDD and p53-
induced protein with a death domain; 
PIDD) for caspase-2, and the well ex-
plained apoptosome (Figure 4D), for cas-
pase-9 (Peter & Krammer, 2003; Tinel & 
Tschopp, 2004; Martinon & Tschopp, 
2007). 
 
 
 
Figure 4: Diagrammatic representation of initia-
tor caspase activation complexes.  
(A) Caspase-1-activating inflammasomes asso-
ciated with IPAF and NAIP may also be part of 
the complex.  
 
 
Table 1: Common known caspases involved in apoptosis (or programmed cell death) 
Cysteinyl aspartic acid-protease (caspase) 
Type name synonyms 
Caspase-2 ICH1, Nedd2 
Caspase-8 FLICE, MACH1, MCH5, FADD-like Ice 
Caspase-9 MCH6, ICELAP6 
 
 
Initiator (or Apical) 
Caspase-10 FLICE2, MCH4 
Caspase-3 CPP32, YAMA 
Caspase-6 MCH2 
 
Effectors (or executioner) 
Caspase-7 MCH3, CMH, ICELAP3 
Caspase-1 ICE 
Caspase-4 ICH2, TX, ICErII 
Caspase-5 ICErIII, TY 
Caspase-11 - 
Caspase-12 - 
Caspase-13 ERICE 
 
 
 
Inflammatory 
Caspase-14 MICE 
A 
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Figure 4: Diagrammatic representation of initia-
tor caspase activation complexes.  
(B) Death-inducing signaling complex (DISC): It 
consists of death ligands (e. g., FAS-L, TNF) 
linked with their receptor (e. g., FAS, TNF-R1) 
and includes FADD associated with DED of 
procaspase-8/10. 
 
 
(C) PIDDosome: it consists of p53-related DD 
containing protein PIDD, RAIDD (having leu-
cine-rich region, LRR) and procaspase-2. 
 
(D) Apoptosome: It is heptameric array of Apaf-
1 molecules, linked with cytochrome c in dATP 
dependent manner allowing the binding of pro-
caspase-9 by means of their CARD.  
These recruitment platforms are multi-
protein complexes consisting of a variety of 
molecules accumulated on a central scaf-
fold protein for example apoptosome scaf-
fold protein Apaf-1, which is comprised of 
three domains such as ligand sensing, oli-
gomerization and caspases recruitment do-
main. Apaf-1 possesses a CARD for cas-
pase-9 recruitment, a NB-ARC domain for 
oligomerization and a WD repeat that 
senses the release of cytochrome c from the 
mitochondria and leads to apoptosis by the 
activation of apoptosome (Jiang & Wang, 
2004; Pop et al., 2006). 
 
Caspase inhibition 
In mammals, inhibition of caspase is 
associated with the proteins belonging to 
IAPs (inhibitors of apoptosis) family (e. g. 
cIAP-1, cIAP-2, ILP-2, survivin, XIAP, 
Livin, BIRC, NAIP) that are differentiated 
by the presence of three baculoviral IAP 
repeats (BIR) and in some, a RING-finger 
motif at the C-terminus (Verhagen et al., 
2001). The IAPs family proteins inhibit the 
function of some initiator (e. g. casp-9) and 
effector caspases (casp-3, and 7) by differ-
ent processes (Deveraux et al., 1998; Sun et 
al., 1999; Kasof & Gomes, 2001), although 
several initiator as well as effector caspases 
(such as casp-1, 2, 6, 8 and 10) are resistant 
to inhibition by XIAP, c-IAP1 and c-IAP2 
(Ho et al., 2005). The action of caspase-8 
has been found to be regulated by a family 
of proteins known as FADD-like ICE 
(FLICE)-inhibitory proteins (FLIPs). It has 
been found that FLICE-inhibitory proteins 
(FLIPs) derived from a virus (v- FLIPs) are 
capable to bind with FADD and casp-8 by 
homotypic interactions and block the re-
cruitment of casp-8 to the DISC leading to 
casp-8 inactivation (Thome et al., 1997). 
Regulation of caspase-9 activity can also be 
achieved by the release of mitochondrial 
proteins Smac ⁄DIABLO and HtrA2 ⁄Omi 
(Verhagen et al., 2000, 2002; Suzuki et al., 
2001). Now it has become clear that ubiq-
uitin-mediated degradation is implicated in 
the regulation of IAPs and proteins with 
which they interact (Vaux & Silke, 2005). 
B 
C 
D 
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Mechanisms of apoptosis 
 
The pathways of apoptosis are ex-
tremely complicated, where energy-
dependent flow of molecular events takes 
place (Figure 5). Mainly two types of apop-
totic pathways such as intrinsic and extrin-
sic (or death receptor) have been well de-
scribed that involve a number of proteins 
(Table 2). 
 
 
 
 
Figure 5: A generalized pathway of DNA damage-induced p53 mediated apoptosis. Various DNA 
damaging signals sensed by ATM/ATR and CHK2 leads to p53 accumulation by interfering the MDM 
2-p53 interaction which inhibits the function of anti-apoptotic Bcl-2 family protein and stimulates the 
proapoptotic BH3-only as well as multidomain Bcl-2 family proteins. Bax/Bak forms oligomers on the 
outer mitochondrial surface through which cytochrome-C, Smac/DIABLO, Omi/HtrA2 comes out of the 
intermitochondrial space in the cytosol, where cytochrome c (cyt-c) binds to Apaf-1 and triggers the 
formation of apoptosome in dATP/ATP dependent manner, which activates casp-9. Smac/DIABLO, 
Omi/HtrA2 blocks the caspase inhibitory function of IAPs family proteins (e. g., survivin) and promotes 
the activation of downstream casp-3/7 by the proteolytic cleavage and conformational change of their 
precursor procaspases that leads to cell death. p53 independent pathway induces the checkpoint 
kinase-2 mediated signaling of E2F-1 towards the pro-apoptotic target genes encoding p73 and pro-
caspases. AIF & Endo-G releasing from mitochondria may also induce cell death by DNA fragmenta-
tion, in caspase independent manner. Question mark indicates that molecular details of the action of 
casp-2 (involved in mitochondrial permeabilization) and IAPs is not well understood. Endoplasmic re-
ticulum (ER) stress induces apoptosis either through direct activation of Bax/Bak or via p53. Damage 
to ER may release Ca2+ which may also promote apoptosis. In addition, UV-B either directly or via 
damaging nuclear DNA, activates death receptor (e. g., Fas, TNF-R) on cell surface by upregulation of 
death ligands (e. g., TNF). UVR may also activate death receptors in a ligand-independent manner by 
induction and trimerization of death receptors which than transduces death signal via their intracyto-
plasmic Fas associated death domain (FADD) and promotes apoptosis either directly or by the release 
of cyto-c from mitochondria.  
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Table 2: Some common proteins involved in extrinsic as well as intrinsic pathway of apoptosis (or 
PCD) (modified from Elmore, 2007). 
 
Proteins Acronym Alternate name Pathway
Apo2 ligand Apo2L TRAIL/TNFSF10 Extrinsic 
Apo3 ligand Apo3L TWEAK/TNFSF12/DR3LG Extrinsic 
Apoptotic protease activat-
ing factor 
Apaf-1 APAF1 Intrinsic 
Apoptosis inducing factor AIF Apaf-3/ICE-LAP6/Mch6 Intrinsic 
B-cell lymphoma protein 2 Bcl-2 Apoptosis regulator Bcl-2 Intrinsic 
BCL2 like 1 Bcl-x BCL2 related protein Intrinsic 
BCL2 related protein, long 
isoform 
Bcl-XL BCL2L protein, long form of Bcl-x Intrinsic 
BCL2 related protein, short 
isoform 
Bcl-XS - Intrinsic 
BCL2 like 2 protein Bcl-w Apoptosis regulator BclW Intrinsic 
BCL2 associated athano-
gene 
BAG BAG family molecular chaperone regulator Intrinsic 
BCL2 associated X protein BAX Apoptosis regulator BAX Intrinsic 
BCL2 antagonist killer 1 BAK BCL2L7, cell death inhibitor 1 Intrinsic 
BCL2 antagonist of cell 
death 
BAD BCL2 binding protein, BCL2L8, BCL2 bind-
ing component 6, BBC6, Bcl XL/Bcl-2 as-
sociated death promoter 
Intrinsic 
BCL2 interacting protein 
BIM 
BIM BCL2 like 11 Intrinsic 
BCL2 interacting killer BIK NBK, BP4, BIP1, apoptosis inducing NBK Intrinsic 
BCL2 binding component 3 Puma B lymphoid tyrosine kinase, p55-BLK, 
MGC10442 Puma BCL2 binding compo-
nent 3 JFY1, PUMA/JFY1, p53 up-
regulated modulator of apoptosis 
Intrinsic 
B-cell lymphoma protein 10 Bcl-10 mE10, CARMEN, CLAP, CIPER Intrinsic 
BH3 interacting domain 
death agonist 
BID p22 BID Intrinsic 
Bik-like killer protein Blk B lymphoid tyrosine kinase, p55-BLK, 
MGC10442 Puma BCL2 binding compo-
nent 3 JFY1, PUMA/JFY1, p53 up-
regulated modulator of apoptosis 
Intrinsic 
Cysteinyl aspartic acid-
protease 8 
caspase-8 FLICE, FADD-like Ice, MACH-1, MCH5 Extrinsic 
Cysteinyl aspartic acid-
protease-9 
Caspase-9 ICE-LAP6, Mch6, Apaf-3 Intrinsic 
Caspase-Activated DNAse CAD CAD/CPAN/DFF40 Intrinsic 
Cell death regulator Aven Aven - Intrinsic 
Death receptor 3 DR3 TNFRSF12, Apo3, WSL-1, TRAMP, LARD, 
DDR3 
Extrinsic 
Death receptor 4 DR4 TNFRSF10A, TRAILR1, APO2 Extrinsic 
Death receptor 5 DR5 TNFRS10B, TRAIL-R2, TRICK2, KILLER, 
ZTNFR9 
Extrinsic 
Death effector domain DED Apoptosis antagonizing transcription factor, 
CHE1 
Extrinsic 
Fatty acid synthetase ligand FasL Fas ligand, TNFSF6, Apo1, apoptosis 
antigen ligand 1, CD95L, CD178, APT1LG1 
Extrinsic 
Fatty acid synthetase re-
ceptor 
FasR Fas receptor, TNFRSF6, APT1, CD95 Extrinsic 
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Table 2 (cont.): Some common proteins involved in extrinsic as well as intrinsic pathway of apoptosis 
(or PCD) (modified from Elmore, 2007). 
 
Proteins Acronym Alternate name Pathway 
Fas-associated death do-
main 
FADD MORT1 Extrinsic 
FLICE-inhibitory protein c-FLIP Casper, I-FLICE, FLAME-1, CASH, 
CLARP, MRIT 
Extrinsic 
High-temperature require-
ment 
HtrA2/Omi Omi stress regulated endoprotease, 
serine protease Omi 
protein A2 
Intrinsic 
Inhibitor of Apoptosis Pro-
teins 
IAP XIAP, API3, ILP, HILP, HIAP2, cIAP1, 
API1, MIHB, 
NFR2-TRAF signaling complex protein 
Intrinsic 
Oncogene Myc Myc c-myc, Myc proto-oncogene protein Intrinsic 
Phorbol-12-myristate-13-
acetate-induced protein 1 
Noxa PMA induced protein 1, APR Intrinsic 
Receptor-interacting protein RIP RIPK1 Extrinsic 
Second mitochondrial acti-
vator of caspases/direct 
IAP 
binding protein with low PI 
Smac/DIABLO - Intrinsic 
Tumor necrosis factor al-
pha 
TNF-α TNF ligand, TNFA, cachectin Extrinsic 
Tumor necrosis factor re-
ceptor 1 
TNFR1 TNF receptor, TNFRSF1A, p55 TNFR, 
CD120a 
Extrinsic 
TNF receptor-associated 
death domain 
TRADD TNFRSF1A associated via death do-
main 
Extrinsic 
Tyrosine 3-
monooxygenase/tryptophan 
5-monooxygenase activa-
tion protein 
14-3-3 14-3-3 eta, theta, zeta, beta, epsilon, 
sigma, gamma 
Intrinsic 
 
 
Another pathway of apoptosis has also 
been recognized which involves perforin/ 
granzyme-A or B (released by cytotoxic T 
lymphocytes and NK cells: perforin/gran-
zyme induced apoptosis). It has been found 
that granzyme A-induced apoptosis is a 
caspase-independent pathway through sin-
gle stranded DNA damage (Martinvalet et 
al., 2005). Both intrinsic as well as extrinsic 
pathways of apoptosis are associated and 
influence each other (Igney & Krammer, 
2002). All the three (intrinsic, extrinsic and 
granzyme B-induced) pathways of apop-
tosis come together on the same point put-
ting to cell death by the activation of cas-
pase-3/7 followed by cell shrinkage, chro-
matin condensation and fragmentation of 
chromosomal DNA, degradation of nuclear 
as well as cytoskeleton proteins etc. (El-
more, 2007). Generally, caspases occur in 
the cells in an inactive form (i. e., pro-
caspase) and once activated can trigger 
other caspases leading to amplification of 
apoptotic signaling pathway followed by 
cell death due to their proteolytic activity. 
Caspases are widely expressed in an inac-
tive pro-enzyme form in most cells and 
once activated can often activate other pro-
caspases, allowing initiation of a protease 
cascade. Some procaspases can also aggre-
gate and autoactivate. This proteolytic cas-
cade, in which one caspase can activate 
other caspases, amplifies the apoptotic sig-
naling pathway and thus leads to rapid cell 
death. 
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Extrinsic pathway of apoptosis 
Increased level of p53 protein was de-
tected in human keratinocytes after UV ir-
radiation (Henseleit et al., 1997). Exposure 
of normal human keratinocytes to UV ra-
diation induces the extrinsic apoptotic 
pathway, which is initiated by the cell sur-
face death receptors, such as TNF1 receptor 
(p55 or CD120a), Fas (CD95/APO-1), DR3 
(Apo3 or WSL1), DR4 (TRAIL-R1) and 
DR5 (TRAIL-R2) (Haupt et al., 2003; Yan 
& Shi, 2005; Elmore, 2007). UV-B-induced 
apoptosis may be triggered by ligand-
dependent (Caricchio et al., 1998) or 
ligand-independent (Rehemtulla et al., 
1997) Fas clustering, with consequent cas-
pase activation (Clément et al., 2007). Acti-
vation of death receptor is followed by the 
formation of death inducing signaling 
pathway complex (DISC), which is com-
posed of adaptor molecule FADD (Fas-
associated death domain) and caspase-8 
(Boldin et al., 1996). FADD is linked with 
caspase-8 zymogens by means of homo-
philic interface with their N-terminal death 
effector domains (DEDs) (Boatright & 
Salvesen, 2003). With the formation of 
DISC, caspase-8 is activated, which either 
directly cleaves and activates the effector 
caspases, or indirectly activates the down-
stream caspases through the cleavage of 
BH3-only protein Bid, leading to involve-
ment of intrinsic pathway of apoptosis (Luo 
et al., 1998). Naik et al. (2007) has revealed 
that UV radiation triggers apoptosis of skin 
keratinocytes mainly through the BH3-only 
protein Noxa. It has been shown that UV 
irradiation results in the activation of sev-
eral members of the MAPK super family, 
such as ERKs, JNKs, and p38 MAPK (Peus et 
al., 1999). Assefa et al. (2000) have shown 
that p38 MAPK pathway mediates apoptosis 
through UV-B irradiation by inducing the 
release of mitochondrial cytochrome-c into 
the cytosol, which is followed by procas-
pase-3 activation. It has also been found 
that c-Jun N-terminal kinase1 (JNK-1) 
plays an important role in UV-induced 
apoptotic cell death (Katagiri et al., 2006a). 
Squamous cell carcinoma antigen (SCCA) 
that belongs to the serpin superfamily 
(SCCA1 & SCCA2) is known in humans 
(Schneider et al., 1995) that are strongly up-
regulated in the upper epidermis of the skin 
after UV irradiation (Katagiri et al., 2006b). 
Furthermore, UV-induced apoptosis was 
significantly decreased when SCCA was 
overexpressed, that strongly suggest that 
SCCA1 binds to JNK-1 to play a protective 
role against UV irradiation in keratinocytes 
by suppressing JNK. Recently Wang and Li 
(2006) have found that the ING3, a tumor-
suppressor protein mainly located in the 
nucleus, plays a critical role in UV-induced 
apoptosis through modulating Fas expres-
sion, resulting in the activation of Fas/Cas-
pase-8 pathway followed by downstream 
caspase cascades activation via Bid cleav-
age. The involvement of Caspase-10 and 
FLICE-like inhibitory protein (FLIP) has 
also been found to be involved in death-
receptor-mediated apoptosis (Juo et al., 
1998; Kischkel et al., 2001; Wang et al., 
2001), however there is disagreement about 
the capability of caspase-10 to functionally 
alternate for caspase-8 in death-receptor 
signaling. FLIP is a caspase-8 homolog 
with certain significant differences and at 
low concentration has been shown to en-
hance Fas-induced caspase-8 activation at 
the DISC, most probably through het-
erodimerization; although at higher concen-
trations FLIP inhibits caspase-8 activation 
(Chang et al., 2002; Micheau et al., 2002). 
 
Intrinsic pathway of apoptosis 
Following DNA damage, increased 
level of Bax and/or decreased level of Bcl-2 
may permeabilize the mitochondria to re-
lease pro-apoptotic factors, such as cyto-
chrome-c, which trigger subsequent activa-
tion of procaspase-9, followed by down-
stream apoptotic effectors (Crompton, 
2000). Recently, it has been found that in 
response to DNA damage, activation of 
caspase-2 is required before mitochondrial 
permeabilization and release of cyto-
chrome-c (Guo et al., 2002; Lassus et al., 
2002; Vakifahmetoglu et al., 2006). Activa-
tion of caspase-2 might occur without proc-
essing of the precursor molecule however, 
oligomerization is an important step for 
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caspase-2 activation (Norbury & Zhi-
votovsky, 2004). Expression of cyclin-D3 
and caspase-2 in human cells potentially 
induces apoptosis, compared with expres-
sion of caspase-2 alone, which shows the 
involvement of cyclin-D3 in caspase-2 acti-
vation (Mendelsohn et al., 2002). After re-
leasing cytochrome-c, it  binds to apoptotic 
protease activating factor Apaf-1 and forms 
a 7-span symmetrical active complex 
‘apoptosome’ in nucleotide dATP/ATP de-
pendent manner (Zou et al., 1999). The 
apoptosome subsequently recruits procas-
pase-9 into its central region to form an ac-
tive holoenzyme, which further activates 
downstream executioner caspases, such as 
caspase-3/7 that leads to PCD (Jiang & 
Wang, 2004). It has been found that in 
mammalian cells, caspase activity is also 
stimulated by one of the pro-apoptotic mi-
tochondrial proteins Smac/Diablo, and 
Omi/HtrA2, which promote apoptosis by 
interfering the action of inhibitor of apop-
tosis (IAP) family protein (e. g., survivin) 
(Verhagen et al., 2002; Song et al., 2003), 
although the inhibition of apoptosis through 
IAPs family is not universal, as survivin is 
unable to prevent the induction of apoptosis 
in ovarian cancer cells by Smac (McNeish 
et al., 2005). In addition to caspase activator 
proteins, some other molecules unrelated to 
caspase activation such as AIF (apoptosis 
inducing factor) (Susin et al., 1999) and 
Endo G (endonuclease G) (Li et al., 2001) 
has also been found to be released from mi-
tochondria that cause apoptosis by DNA 
fragmentation and subsequent chromosomal 
condensation. Recent evidence suggests 
that Bax/Bak can also be localized in the 
endoplasmic reticulum (ER) and gets acti-
vated in response to ER stress, leading to 
calcium depletion and murine caspase-12 
activation (Scorrano et al., 2003). In addi-
tion to ER stress activation of Bax/Bak by 
Puma, Li et al. (2006) have identified Noxa 
as a novel BH3-only protein that is acti-
vated by ER stress. Furthermore, in mouse 
embryo fibroblasts (MEFs), it has been 
found that induction of Noxa and Puma by 
ER stress is largely dependent on p53 and 
both proteins (Puma/Noxa) contribute to 
ER stress-induced apoptosis. 
In addition to other organisms, PCD has 
also been suggested in various phytoplank-
ton species (Franklin et al., 2006) such as 
cyanobacteria (e. g., Trichodesmium sp., 
Anabaena flos-aquae) (Ning et al., 2002; 
Berman-Frank et al., 2004), green algae 
(e. g., Dunaliella tertiolecta) and dinoflag-
ellates (e. g., Peridinium gatunense) (Vardi 
et al., 1999). However, it is not very clear 
how PCD is operating in phytoplankton and 
whether it has greater similarities with ani-
mal, plant, or fungal models? The presence 
of key apoptotic enzymes such as paracas-
pase (in bacteria), metacaspase (in 
plant/fungi) and caspases (in animals) that 
share common active sites (Uren et al., 
2000) are considered to be highly conserved 
across taxa (Aravind et al., 2001), although, 
the presence of animal cell death regulator, 
such as Bcl-2 family and p53 in all the life 
forms is still in dispute. Furthermore, the 
mitochondria that play a central role in 
animal apoptotic pathway, its role in plant 
and protists is not clear (Franklin et al., 
2006). 
 
Apoptosis vs. necrosis 
 
Apoptosis and necrosis (accidental cell 
death; ACD) are two independent, sequen-
ced as well as simultaneous processes 
(Zeiss, 2003) that can be induced by several 
stimuli such as high temperature, UV radia-
tion, ionizing radiation, oxidative stress and 
cytotoxic anticancer drugs. Apoptosis is a 
synchronized and frequently energy-depen-
dent process that involves the activation of 
a set of cysteine proteases (caspases) and a 
complex cascade of events, while cell death 
by means of necrosis does not involve gene 
expression and is a passive externally-
driven process that results after cell death in 
the absence of any metabolic self-involve-
ment (Franklin et al., 2006). The process of 
apoptosis is morphologically distinct from 
necrosis in many of its characteristics such 
as cell shrinkage, cytoplasmic condensa-
tion, DNA fragmentation, chromatin con-
densation, nuclear fragmentation, cyto-
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plasmic membrane blebbing and formation 
of apoptotic bodies whereas necrosis in-
volves loss of membrane integrity, cell 
swelling, formation of cytoplasmic vacu-
oles, swollen endoplasmic reticulum, dis-
tended or ruptured mitochondria, ly-
sosomes, lysis and release of the cytoplas-
mic contents into the surrounding tissue 
(Majno & Joris, 1995; Trump et al., 1997; 
Chamond et al., 1999) leading to inflamma-
tory reaction which is absent in apoptotic 
cells (Kurosaka et al., 2003) (Figure 6). Re-
cently, it has been found that alkylating 
DNA damage stimulates a necrotic type of 
PCD through the poly (ADP-ribose) poly-
merases (PARP) and apoptosis inducing 
factor (AIF) and it was observed that, simi-
lar to apoptosis, necrosis may possibly be a 
highly regulated cell death program (Mou-
barak et al., 2007). The process of necrosis 
may occur in a controlled fashion (Vanden 
Berghe et al., 2004; Saelens et al., 2005; 
Zong & Thompson, 2006) and analysis of 
necrotic pathway may provide novel oppor-
tunities to destroy apoptosis-resistant tumor 
cells. 
 
 
Figure 6: Diagrammatic illus-
tration showing the morpholo-
gical distinctiveness occurring 
during apoptosis and necrosis. 
The cell death by apoptosis is a 
normal and energy (ATP) de-
pendent pathway caused by a 
number of endogenous as well 
as exogenous stimuli. During 
apoptosis, decrease in cell vol-
ume, nuclear changes with 
chromatin condensation, mar-
gination and fragmentation fol-
lowed by blebbing and break-
down of intact cell and nuclear 
membranes takes place. It re-
sults into the formation of small 
fragmented apoptotic bodies 
having cytoplasmic contents 
surrounded by cell membrane 
which are removed by the 
process of phagocytosis in the 
extracellular environment 
avoiding the inflammatory reac-
tion. Necrosis is an unusual 
and unintended process 
caused by external cell injury 
by a number of stimuli. It is 
characterized by the increase 
in cell volume followed by 
enlargement of cell organelles 
including nucleus, loss of mem-
brane integrity and release of cellular contents which consists of certain enzymes such as hydrolases 
that influence the adjoining cells leading to inflammatory reaction in the adjacent tissue. 
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Malfunctioning of apoptosis and 
pathogenesis 
 
Improper apoptosis or malfunctioning 
of individual apoptotic machinery may 
cause several human diseases like cancer, 
neurodegenerative as well as several types 
of autoimmune disorder (Barr & Tomei, 
1994; Thompson, 1995; Chun et al., 2002) 
(Figure 7). It has been found that unneces-
sary cell death and unsound regulation of 
caspase activity are associated with certain 
diseases such as Alzheimer’s disease, Park-
inson’s disease and Huntington’s disease. 
Augmented activities of caspases-8 and -9 
have been observed in peripheral blood 
mononuclear cells of Alzheimer’s disease 
patients (Tacconi et al., 2004) and in brain 
tissues of Alzheimer’s as well as Parkin-
son’s disease patients (Viswanath et al., 
2001; Rohn et al., 2002; Yew et al., 2004). 
Huntington’s disease, a neurodegenerative 
disorder, has also been found to be caused 
by increased activity of caspase-10 in a 
manner similar to caspase-8 (Miyashita et 
al., 2001). Mutations on Fas and Fas ligand 
(Fas-L) in humans may cause a complicated 
immune disorder like autoimmune lym-
phoproliferative syndrome (ALPS), a sem-
blance of murine lymphoproliferation (lpr) 
and generalized lymphoproliferative disor-
der (gld) (Jiang & Wang, 2004).  
 
 
 
 
Figure 7: Some common diseases associated with malfunctioning of apoptosis or PCD (modified from 
references Chamond et al., 1999 and Alam, 2003) 
 
 
Malfunctioning of apoptosis 
Inadequate apoptosis  Extreme apoptosis 
Frequent infections 
• Alzheimer’s disease 
• Parkinson’s disease 
• Huntington’s disease 
• Stroke 
• Brain trauma 
• Spinal cord injury 
• Amyotrophic lateral 
   sclerosis (ALS) 
• Retinitis pigmentosa 
• Epilepsy, etc. 
Neurodegenerative  
diseases 
Cardiovascular diseases
• Heart failure 
• Myocardial 
    infarction 
• Stroke 
Other disorders 
• Inflammation 
• Sepsis 
• Diabetes (type-I) 
• Alopecia, etc. 
• AIDS 
• Polycystic kid-
ney, etc. 
• Colorectal 
• Hepatic 
• Prostate 
• Leukaemias 
• Neuroblastoma, etc. 
 
Autoimmune disorders 
• Systemic lupus 
   erythematosus 
• Myastenia gravis 
Restenosis 
• Viral infections 
Cancer 
Haematologic diseases 
• Aplastic anaemia 
• Myelodysplastic 
   syndrome 
• T CD4+ lympho-  
    cytopenia, etc. 
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The three autosomal dominant diseases 
such as Muckle Wells syndrome, familial 
cold auto-inflammatory syndrome and 
chronic infantile neurological cutaneous 
and articular (CINCA) syndrome caused by 
missense mutations in the NACHT domain 
of NALP3 protein are closely related to 
autoinflammatory syndromes distinguished 
by periodic fever, skin rashes, amyloidosis 
and development of neurological compli-
cations (Martinon & Tschopp, 2007; 
Aganna et al., 2002; Dode et al., 2002). It 
has been suggested that loss of caspase-14 
expression is associated with progression of 
ovarian cancer (Krajewska et al., 2005) and 
the mutation in p53 gene may cause neo-
plastic diseases (Chamond et al., 1999). 
Thus it seems that apoptotic pathway is as-
sociated with several biological processes 
and plays a vital role in regulating various 
diseases. 
 
Significance of apoptosis in  
biological systems 
 
Apoptosis (or PCD) is an evolutionarily 
conserved and extremely synchronized 
form of cell death to facilitate the deletion 
of redundant, infected, injured or ma-
lformed cells during the normal life span in 
various biological systems which is an es-
sential course of action in maintaining ho-
meostasis in multicellular organisms. It is 
usually implicated in embryogenesis, meta-
morphosis, immune system and normal 
adult tissue remodeling as well as in a 
number of pathological disorders such as 
cancer, autoimmunity and degenerative dis-
eases. Generally cancer cells themselves are 
more prone to undergo apoptosis and a 
comprehensive understanding of the mo-
lecular pathways that regulate apoptosis 
will assist in investigating novel cancer 
chemotherapeutic targets (Bailey et al., 
2005) which in turn would offer new oppor-
tunities for the discovery and development 
of drugs (Alam, 2003). Stimulation of dis-
abled p53 pathways has been suggested as a 
potential mode of therapy for cancer (Wen 
et al., 2003). A large number of non-
genotoxic compounds such as Nutlin-3 
(Vassilev et al., 2004), RITA (reactivation 
of p53 and induction of tumor cell apop-
tosis) (Issaeva et al., 2004), HLI98 (Yang et 
al., 2005) has been reported that leads to 
p53-dependent apoptosis (Coll-Mulet et al., 
2006; Secchiero et al., 2006) by disrupting 
the MDM2-p53 interaction. Several other 
compounds such as Exotoxin-A (ETA) 
(Christopher et al., 2004; Chang & Kwon, 
2007), Isokotomolide-A (IKA) (Chen et al., 
2007), Ellipticines (Stiborova et al., 2006), 
MDPTQ (Shenoy et al., 2007) have re-
cently been identified as potent apoptotic 
inducer compounds, that may be useful for 
anticancer therapy. Several recent studies 
have revealed a number of natural as well 
as synthetic anticancer drugs (Table 3) that 
act through the induction of apoptosis to 
prevent tumor promotion, progression, and 
the occurrence of cellular inflammatory re-
sponses other than necrosis (Nicholson, 
2000). Anticancer therapy may cause both 
apoptosis as well as autophagic cell death, 
however, there is little information about 
the connection between autophagy and 
apoptosis, but recently it has been shown 
that autophagy gene5 (Atg5) can bind to 
Bcl-XL and induce apoptosis, which indi-
cates that apoptosis and autophagy could be 
interconnected by molecular interaction be-
tween Atg and Bcl-2 family proteins 
(Yousefi & Simon, 2007). UV-induced 
apoptotic pathways could assist in modulat-
ing the susceptibility of cells to undergo 
apoptosis either to improve the efficiency of 
cancer treatments or avoid the unwanted 
death of normal cells (Assefa et al., 2005). 
From the past few years, certain photosensi-
tizing drugs are being employed to induce 
apoptosis for the treatment of cancer and 
other non-cancerous or abnormal cells 
(Dougherty, 1993; Oleinick et al., 2002; 
Zawacka-Pankau et al., 2008), which is 
termed as photodynamic therapy (PDT) in-
duced apoptosis. Most photosensitizers for 
PDT are efficient producers of reactive 
oxygen species (ROS) such as singlet oxy-
gen which is the dominant mechanism for 
PDT-induced apoptosis in cells and tissues 
(Oleinick et al., 2002). In many cases PDT 
is highly efficient in inducing apoptosis, 
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though it can induce apoptosis or necrosis 
or both (Oleinick et al., 2002). A number of 
photosensitizers such as photofrin, ben-
zoporphyrins, hypericin, m-tetrahydroxy-
phenylchlorin (mTHPC or Foscan), porphy-
rin, hematoporhyrins (Hp), protoporphyrin 
IX (PpIX), benzoporphyrin derivative 
(BPD), benzyl ester 5-ALA (Figure 8) etc. 
have been approved by regulatory agencies. 
These porphyrinogenic sensitizers may in-
duce apoptosis through different pathways 
(Kralova et al., 2006; Saczko et al., 2007; 
Hilf, 2007; Kramer & Plaetzer, 2008; 
Zawacka-Pankau et al., 2008). Genetic evi-
dence specifies that the cell surface death 
receptor-mediated apoptosis is significant 
for the functioning of a normal immune 
system, since mutations on Fas and Fas 
ligand (Fas-L) in humans may cause a 
complicated immune disorder like autoim-
mune lymphoproliferative syndrome 
(ALPS) (Jiang & Wang, 2004). Normally, 
exposure of cells to UV radiation results in 
increased cell death through apoptosis by 
increasing the activities of both the mito-
chondrial derived intrinsic and plasma 
membrane derived extrinsic apoptotic 
pathways (Kulms & Schwarz, 2000). A 
family of cysteine proteases (caspases) has 
been found to have an important role in this 
process that leads to organized destruction 
of the cell by a restricted cleavage of a vari-
ety of crucial cellular substrates.  
 
Table 3: Some apoptotis-inducing natural as well as synthetic compounds used in cancer chemotherapy 
 
Compound Source Structure Probable Mechanisms Reference 
Nutlin 3 Synthetic  
(cis-imidazoline  
derivatives) 
N
N
N NH
O
O
O
Cl
Cl
O
 
Block MDM2 activity by 
disrupting the MDM2-p53 
interaction 
Vassilev et 
al., 2004; 
Secchiero 
et al., 2006  
RITA Synthetic   
S
HO O
S
 
 
Block MDM2-p53 interac-
tion and ubiquitation 
Issaeva et 
al., 2004 
 
ETA Pseudomonas  
aeruginosa 
- induces cell cycle arrest 
and caspase-3 activation 
Christopher 
et al., 2004; 
Chang and 
Kwon, 2007 
IKA Cinnamomum  
kotoense 
O
HO
H
O
H
 
Block G0/G1 cell cycle 
progression and also de-
crease the interaction of 
p53–MDM2 
Chen et al., 
2007 
 
PRIMA-1 Synthetic (Azabi-
cyclooctan-3-one 
derivatives) 
 
N
CH2OH
CH2OH
O  
reinstate sequence-
specific DNA binding and 
reactivate mutant p53 
proteins 
Bykov et al., 
2003 
 
HLI98 Synthetic (7-
nitro-5-
deazaflavin  
derivatives ) 
 
HN
N NO
O
Cl
NO2
 
inhibits HDM2 ubiquitin 
ligase activity 
Yang et al., 
2005 
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Table 3 (cont.): Some apoptotis-inducing natural as well as synthetic compounds used in cancer  
chemotherapy 
 
Compound Source Structure Probable Mechanisms Reference 
PD paris polyphylla  
O
O
O
O
OH
HO
OO
OH
HO
O
O
HO
HO OHOH
 
acts on mitochondria and 
elicits dissipation of 
transmembrane potential 
(∆ψm), generation of 
ROS, and release of cyto-
chrome c and AIF 
Cheung et 
al., 2005 
 
 
 
Shikonin  
(Human Colo-
rectal Carci-
noma Cells) 
 
 
 
Lithospermum  
erythrorhizon 
 
 
HHOOHO
HO O  
loss of mitochondrial 
membrane potential, reac-
tive oxygen species 
(ROS) generation, cyto-
chrome c release, and 
subsequent induction of 
pro-caspase-9 and -3 
processing 
Hsu et al., 
2004 
EOKA  Espeletia  
schultzii;  
Espeletia  
grandiflora 
COOH
H
H
O
 
activates caspace-3 and 
caspace specific cleavage 
of PARP, and also in-
duces nucleosomal DNA 
fragmentation as well as 
reduction of Bcl-2 protein 
level 
Yarimar et 
al., 2008 
Ellipticine Ochrosia  
borbonica,  
Excavatia  
coccinea 
 
N
H
N
 
accumulation of dephos- 
phorylated mutant p53 
 
Kuo et al., 
2005;  
Stiborova et 
al., 2006 
MDPTQ 
 
Quinoline  
derivative 
 
N S
N
N
HN (CH2)3
N
C2H5H5C2
H3C
 
 
increase in ROS followed 
by loss of membrane po-
tential (∆ψm)  
Shenoy et 
al., 2007 
Hop Bitter 
Acids (e. g. 
humulone) 
Humulus lupulus 
L. 
 
O O
R
O
H
HO
HO
 
Fas activation and mito-
chondrial dysfunctions 
Chen & Lin, 
2004 
Cinnamalde-
hyde 
Cinnamomum 
osmophloeum 
  
CHO
 
loss of ∆ψm and release 
of cytochrome c into cyto-
sol, by the imbalance of 
Bcl-2 family of proteins 
 
Huang et 
al., 2007 
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Table 3 (cont.): Some apoptotis-inducing natural as well as synthetic compounds used in cancer  
chemotherapy 
 
Compound Source Structure Probable Mechanisms Reference 
Apicidin Fusarium sp.  
N
N
N
N
H
H
H
O
O
O
O
O
H3C
H3C
H3C
N
O
H3C
 
induces Fas and Fas-L, 
cytochrome c release into 
the cytosol, and activation 
of casp-9 and 3 
 
Kwon et al., 
2002 
EDS (epidiox-
ysterols) 
Meretrix lusoria  
HO
O
O
 
induces chromatin con-
densation, and sub-G1 
cell population 
Pan et al., 
2007 
Aloe-emodin Aloe vera  
HO
OH OHO
O
 
blocks casein kinase II 
activity and phosphoryla-
tion of Bid and induces Aif 
and cytochrome c 
Chen et al., 
2007 
Curcumin Curcuma longa  
OO
HO OH 
induces the production of 
ROS and downstream 
activation of JNK as well 
as activation of caspases 
9, 3, and 8 
Johnson & 
Mukhtar, 
2007 
Hormonemate Hormonema 
dematioides 
 
HO
HO HO
HO HO
O
O
OO
O
O
O O
O
HO
O
 
 
 
 
 
 
 
induces caspae-3 activity 
Filip et al., 
2003 
ClBPAs Synthetic  
(derivatives of 
bisphenol A) 
 
CH3
C
CH3
Cl
OHHO
 
induces DNA fragmenta-
tion followed by activation 
of caspase 3, 8 and 9  
Mutou et 
al., 2008 
Cinnamalde-
hyde 
Cinnamomum 
cassia 
 
 
H
O
 
induces the ROS-
mediated mitochondrial 
permeability transition and 
resultant cytochrome c 
release 
Ka et al., 
2003 
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Figure 8: Structure of some photosensitizers used in PDT-induced apoptosis. (A) Photofrin, (B) Verte-
porfin (benzoporphyrin derivative), (C) Protoporphyrin IX (D) Hypericin and (E) m-Tetrahydroxy-
phenylchlorin (mTHPC or foscan) 
 
 
CONCLUSION 
 
Apoptosis is an exceedingly complica-
ted phenomenon, with energy-dependent 
flow of molecular events accomplished by 
two types of pathways such as intrinsic and 
extrinsic that involves the activation of a set 
of cysteine proteases known as “caspases”. 
The process of cell death by means of apop-
tosis (PCD) and necrosis (ACD) is accom-
panied by a number of distinctive morphol-
ogic and metabolic changes. Apoptosis 
plays a significant role in survival by main-
taining the homeostasis in multicellular or-
ganisms as well as in the management of 
many diseases, since malfunctioning of 
apoptotic pathway may cause several hu-
man diseases like cancer, neurodegenera-
tive as well as several types of autoimmune 
disorder. Presently, large numbers of syn-
thetic as well as natural compounds have 
been found that are pharmacologically 
highly effective against certain diseases 
through inducing the apoptosis of target 
cells such as cancerous cells. These com-
pounds may promote the development of 
novel remedy based on the inflection of 
apoptosis. As of now, the basic mechanisms 
of apoptosis have been established, but its 
implications for therapeutic purposes have 
still to be worked out. 
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